ArticleFrontiers in aging neuroscience2018

Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging.

Nathan Duval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.